agosto 2024 - Global Industry Trends

Asia-Pacific Emerges as Fastest-Growing Region in Cloud Services Market

According to the latest market research study published by P&S Intelligence, the global cloud services market is estimated to have reached USD 882.5 billion in 2024, with projections to soar to USD 2,273.8 billion by 2030, reflecting a compound annual growth rate (CAGR) of 17.1% over the forecast period.

A pivotal factor in this growth is the Internet of Things (IoT), wireless communications, and connected devices. Cloud computing serves as a crucial enabler, providing the necessary processing power and storage for IoT and other applications. This allows organizations to store information on servers located remotely, ensuring continuous connectivity and real-time data exchange between devices and monitoring software. This integration of wireless communication devices with cloud services, known as wireless networking cloud integration, offers scalability, security, and flexibility at a lower cost compared to traditional networks.

The market is further propelled by the expanding economies in developing countries, the increasing number of industries and enterprises establishing manufacturing units, and the growing awareness of the substantial benefits that businesses and individuals gain from cloud services. By adopting cloud services, enterprises can significantly reduce their annual recurring costs by eliminating the need for substantial investments in physical IT infrastructure.

Key Insights:

Public Cloud Dominance: Public cloud services lead the market, holding a 55% share in 2024, driven by the demand for cost-effective, scalable, and secure solutions.

Hybrid Cloud Growth: The hybrid cloud segment is expected to grow at a 17.5% CAGR from 2024 to 2030, combining the advantages of private and public clouds for optimized resources and increased flexibility.

SaaS Leading the Market: Software as a Service (SaaS) is the largest segment, with a 50% market share in 2024, and the fastest-growing, with a 17.6% CAGR during the forecast period, due to its cost-efficiency, low maintenance, easy deployment, and rising hybrid cloud adoption.

Large Enterprise Demand: Large enterprises, which hold a 65% market share in 2024, require cloud services for scalability, operational efficiency, seamless collaboration, and robust security.

IT & Telecom Sector: The IT & telecom sector accounted for 25% of the market in 2024, utilizing cloud services for data analysis, storage, and enhanced security. Strategic collaborations, such as the one between Airtel and Vultr in February 2023, are key drivers of growth in this sector.

BFSI Sector Growth: The banking, financial services, and insurance (BFSI) sector is expected to witness a 17.8% CAGR from 2024 to 2030, driven by the need for cloud services in payment gateways, digital wallets, online funds transfer, and data privacy compliance.

Regional Insights: North America led the global market with a 45% share in 2024, thanks to early adoption of advanced technologies and the presence of cloud service giants like Amazon, Microsoft, Oracle, Google, and IBM. Meanwhile, Asia-Pacific is the fastest-growing region, with a 17.7% CAGR during the forecast period, fueled by economic growth and the adoption of advanced technologies such as blockchain, robotics, AI, IoT, and 5G.

Global GIS Market to Double by 2030, Fueled by Urbanization and Technological Advances

In 2024, the global geographic information system industry is set to generate an estimated USD 14.8 billion in revenue, with a compound annual growth rate (CAGR) of 13.1% projected over the forecast period, reaching USD 31.2 billion by 2030. This growth is driven by rising investments, the increased availability of spatial data and cloud technology, and the growing demand for GIS solutions in the transportation sector.

GIS software plays a pivotal role in smart city projects, aiding in every stage from site selection and land acquisition to planning, design, visualization, construction, project management, operations, and reporting. It processes geospatial data gathered from satellite imaging, aerial photography, and remote sensors, providing a holistic view of land and infrastructure. As governments around the world prioritize sustainable urban development, the demand for GIS is expected to rise significantly in the coming years.

In the transportation industry, GIS technology is applied in accident analysis, highway maintenance, traffic modeling, and route planning, enabling better monitoring, planning, and management of complex transportation systems. Companies like Ola and Uber utilize GIS in their mobile apps through virtual meters to locate the nearest available vehicles and automate payment calculations based on travel distance.

Moreover, GIS assists in route planning by analyzing key economic and demographic factors to determine optimal routes, assessing existing routes, gathering data, and informing users of any changes.

Key Insights:

Hardware Dominance: In 2024, hardware accounts for 50% of the GIS market, driven by the need for initial computer systems and the widespread use of GNSS/GPS antennae.
Software Growth: Software is expected to grow at a 13.5% CAGR from 2024 to 2030, fueled by the adoption of cloud-based GIS and real-time data analysis capabilities.
Mapping Applications: Mapping holds a 40% market share in 2024, with urbanization driving demand for urban planning applications such as land acquisition and environmental impact assessments.
Location-Based Services: These services are projected to grow at a 13.6% CAGR due to increased smartphone adoption and improved geographical accuracy.
Cartographic Services: Dominating with a 45% market share in 2024, cartographic services support data management and spatial analysis across various sectors.
Digital GIS Growth: Expected to grow at a 13.4% CAGR, digital GIS is driven by demand for advanced data analysis tools and the discovery of spatial relationships.
Government Sector: Holding the largest share at 35% in 2024, the government sector uses GIS for community, urban, and rural planning, as well as natural disaster management.
Agriculture Expansion: The agriculture sector is growing at a 13.8% CAGR from 2024 to 2030, supported by increased grain production and the adoption of GIS for crop health analysis.
Regional Leadership: North America leads the GIS market with a 45% share in 2024, driven by public sector applications in homeland security and defense. Meanwhile, Asia-Pacific is expected to grow at the highest CAGR of 13.7%, driven by urbanization and government investments in GIS infrastructure.
Market Consolidation: Small firms in China and India benefit from SaaS-based cloud infrastructure, while major players dominate in developed regions like Europe and North America.
R&D Investment: Companies are increasingly investing in research and development to enhance GIS products and services globally.

Building Inspection in Saudi Arabia: $316.7M by 2030

The Saudi Arabian building inspection services industry size will be projected at USD 182.9 million in 2024, and it is estimated to attain USD 316.7 million by the end of the decade, developing at a CAGR of 9.6% during the projection period. This will be because of the growing construction activities, increasing expenditure in real estate, and surging populace in the market.

COVID-19 transformed the industry by giving the opportunity for remote inspections via utilizing digital tools. This helps in decreasing human effort and guaranteed the steadiness of business during that time.

The approach to remote assessments and inspections makes the overall cost of the process considerably lower. In addition, the outcome of inspection and documentation can be forwarded electronically taking their work under paperless systems and the actual exchange of documents. Technologies help to make an inspection report through videography, images, and notes which can be dispatched electronically to the related parties.

With the development of new cities across Saudi Arabia; NEOM, residential complexes as well as industrial facilities there is increased demand for building inspection services. They are liable for the quality of construction as well as the soundness and stability of the structures. For information, the National Development Fund Saudi Arabia revealed that the government proclaimed approximately 1429 infrastructural projects in 2022.

Key Insights

In 2024, the home inspection category grips the major share of 45% and is projected to advance with a CAGR of 10% during the forecast period.

Comprehensive house inspections comprise assessments of external components, electric systems, roofs, foundations, HVAC systems, plumbing, attics, basements, and crawl spaces.

Specialty inspections shelter facilities like sewer and septic systems, roof inspections, lawn, Irrigation, property protection, and annual maintenance assessments.

Demand for specialty inspections is developing because of augmented consumer awareness of exact problems.

The outsourced category leads the Saudi Arabian building inspection services industry with a 65% share and an estimated CAGR of 9.8%.

Outsourcing guarantees advanced quality inspections and lets businesses emphasize core operations.

Dedicated inspection businesses have professional teams knowledgeable in guidelines and practices, leading to advanced precision.

Al-Riyadh is estimated to advance with the highest CAGR of 10.2%, propelled by the high count of households and industrial and commercial developments.

Residential construction in Riyadh is rising with significant public and private investment, including a SR 72 billion project for 108,000 units.

The Eastern province holds the largest share (40%) in 2024, driven by large-scale construction activities and stringent safety regulations.

Saudi Arabia’s Geospatial Revolution: Impact on Real Estate and Logistics

The Saudi Arabian geospatial analytics market will generate an estimated revenue of USD 414.8 million in 2024, which is expected to witness a CAGR of 9.5% during 2024−2030 and reach USD 714.8 million by 2030.

Such information is becoming popular because it helps to visualize and analyze movements, places, and patterns. This is especially important for the development of smart cities as architects employ analysis to determine the best locations for new investments.

It is also very useful in consumer services since the exact location is required for goods to be delivered. This information is helpful to the logistics companies to ensure that the link between the service providers and the consumers is seamless. Even the transportation sector stands to gain because it can understand barriers and traffic flow to enhance traffic direction.

Another factor influencing the market dynamics is the Saudi Arabian government’s plans for infrastructure development and efficient utilization of resources. Some of the government-led programs include the MOMRA smart city program and the Saudi Geological Survey (SGS).

For instance, the Riyadh Development Authority (RDA) leverages geospatial analytics to track environmental factors and transportation. In 2022, KSA will establish higher research centers in geographical sciences to advance geospatial science as well as address the demand for skills in line with Vision 2030.

Key Insights

• In 2024, geovisualization grips a 50% industry share in and is projected to uphold this in the coming years.

• This technology analyzes and pictures geographical info for improved resource planning and optimization.

• Geovisualization is vital in handling natural resources and agriculture.

• It offers info on crop production, water reserves, and soil conditions.

• In 2024, the real estate category will account for 35% of the industry.

• Geospatial analytics are very high in demand for land usage planning and management in real estate.

• Saudi Arabia has reserved USD 1000 million for real estate and infrastructure projects.

• Plans include eight new cities along the Red Sea coast and over 1.3 million new houses by 2030.

• The software component holds a 55% market share in 2024 and is expected to continue leading.

• Continuous advancements in software technology, such as cloud computing, AI, and machine learning, drive adoption.

• Geospatial analytics software offers sophisticated tools for data picturing, interpretation, and analysis.

• Such tools aid several industries such as transportation, agriculture, and industry.

• The Eastern region leads the Saudi Arabian geospatial analytics market with a 45% share in 2024.

• This region is a hub for commercial activities like trade, logistics, retail, and oil and gas exploration and production.

• The oil and gas industry relies on geospatial analytics for resource management and production optimization.

• Geospatial technology is widely used in the Eastern region for route and traffic flow management.

• In February 2024, Saudi Arabia launched SpaceKnow, advancing the use of satellite imagery and AI analysis across industries.

North America Leads, APAC Emerges as Fastest-Growing Region in Biologics Safety Testing

The biologics safety testing market was valued at USD 3,998.1 million in 2024 and is projected to reach USD 9,370.3 million by 2030, growing at a CAGR of 15.3%. This growth is driven by the rising prevalence of diseases, increasing demand for biosimilar and biologic drugs, expanding investment in research and development, and growing outsourcing activities.

In 2022, the vaccines segment, based on application, dominated the market with nearly a 30% share. This dominance is largely attributed to the increasing incidence of various diseases over time. Additionally, the management, prevention, or treatment of chronic diseases such as cancer and diabetes, as well as infectious diseases like measles and influenza, require vaccine administration.

The cellular and gene therapy segment is expected to grow at a CAGR of approximately 12% in the coming years, primarily due to ongoing research and advancements in cellular and gene therapies. Among end users, biopharmaceutical companies lead the market, driven by the rising incidence of disease outbreaks in recent years, which has significantly increased the demand for biologics. Moreover, many countries are investing heavily in their healthcare sectors and promoting vaccine administration for serious viral infections like measles, COVID-19, Zika, and Ebola.

In 2022, the bioburden testing segment held the largest share in the biologics safety testing market. This can be attributed to public organizations like the WHO, which have set standards to ensure the sterility of medicines, applicable to various biologics such as tissues, cells, vaccines, and blood products. These regulations are in place to ensure that the products are free from contaminants and meet safety standards.

The endotoxin testing segment, on the other hand, is expected to grow at a significant CAGR in the coming years, mainly due to the increasing use of this test in the production of therapeutics to reduce endotoxin burden. North America is the largest contributor to the market, driven by the strong presence of major companies, the high incidence of both non-communicable and infectious diseases such as diabetes and COVID-19, and a well-developed healthcare infrastructure.

The Asia-Pacific (APAC) region is anticipated to witness the fastest growth, with a CAGR of 15%, in the coming years. This growth is attributed to the rising prevalence of serious illnesses, large patient populations, and supportive government policies backing R&D initiatives in the region. As the demand for biosimilar and biologic drugs increases, the biologics safety testing market is expected to continue its upward trajectory in the years ahead.

Revolutionizing Healthcare: The Impact of Cellular Health Screening

In today’s healthcare landscape, where prevention is paramount, cellular health screening emerges as a groundbreaking method for understanding and improving our overall well-being. Unlike traditional health check-ups, which provide a broad overview of our physical health, cellular screening delves into the very essence of physiological functions, offering insights at an unprecedented level in modern medicine.

What is Cellular Health Screening?

Cellular health screening involves assessing the function, structure, and overall condition of cells. This advanced diagnostic tool surpasses conventional tests by enabling healthcare providers to identify subtle cellular abnormalities before they escalate into significant health issues. By examining health markers, mitochondrial function, cellular integrity, and oxidative stress, practitioners gain a comprehensive view of the internal environment of the body.

The Significance of Mitochondrial Function

Mitochondria, known as the powerhouses of cells, are crucial for cellular health. During cellular health screenings, special emphasis is placed on mitochondrial function due to their essential role in energy production. Reduced mitochondrial efficiency can lead to various health issues, including fatigue, aging, and chronic diseases. Evaluating mitochondrial health helps individuals proactively address energy imbalances and enhance overall vitality.

Oxidative Stress and Antioxidant Defense

Oxidative stress arises from an imbalance between free radicals and antioxidants in the body, leading to cellular damage and accelerated aging. Cellular health screening measures oxidative stress levels, helping individuals gauge their body’s vulnerability to oxidative damage. This information enables doctors to design interventions aimed at bolstering antioxidant defenses, potentially reducing the risk of chronic diseases associated with oxidative stress.

Early Detection and Prevention

One of the most significant benefits of cellular health screening is its ability to detect cellular abnormalities early. By identifying minor changes at the cellular level, healthcare professionals can intervene before conditions worsen, aligning with the principles of precision medicine. This proactive approach facilitates personalized interventions tailored to an individual’s unique biological makeup.

Customized Wellness Approaches

Cellular health screening empowers individuals to take charge of their well-being by providing actionable insights. With a detailed understanding of their cellular health, people can work with their healthcare providers to develop personalized wellness plans. These plans may include lifestyle changes, customized nutritional supplements, and targeted physical activities aimed at correcting cellular imbalances and enhancing overall health.

In Conclusion

The growing emphasis on extending healthy life expectancy, rising healthcare expenditure, increasing disease prevalence, and an aging population are driving the demand for cellular health screening. By the end of this decade, the cellular health screening industry is projected to reach a value of USD 5,512.8 million.

North America Leads Global Pharmaceutical Sterility Testing Market Amid Growing R&D and Regulatory Support

In 2024, the global pharmaceutical sterility testing market is expected to reach USD 1,959.9 million, with a projected CAGR of 11.5% between 2024 and 2030. By 2030, the market is anticipated to achieve a value of USD 3,763.0 million.

This market expansion is driven by the growth of pharmaceutical and biotechnology companies, an increase in their research and development activities, a rising incidence of diseases, and substantial government investments in the healthcare sector.

The prevalence of hematological cancers is increasing. According to The Leukemia & Lymphoma Society, someone in the U.S. is diagnosed with lymphoma, myeloma, or leukemia every three minutes. Biopharmaceuticals, including gene, immune, and cell therapies, are increasingly being adopted as alternative treatments for hematological cancers due to their high potency and effectiveness.

Sterility testing, particularly membrane filtration, has been a dominant segment in recent years, holding a 25% revenue share. Membrane filtration is widely used due to its high sensitivity, especially in testing liquid dosage forms. Its compatibility with samples containing bacteriostatic and fungistatic agents, as well as preservatives, is fueling the growth of this category.

Leading companies in the pharmaceutical excipients market are focusing on expanding their operations, launching new products, and forming joint ventures with universities. The need for innovative excipients is encouraging continuous introduction of advanced and modified excipients.

In terms of product type, the kits & reagents segment led the industry with a 50% revenue share in 2023, largely due to the widespread availability and ease of use of these products. The repetitive purchasing of these items is also contributing to the growth of this segment.

North America led the market in 2023, holding a 55% revenue share. This dominance is attributed to the presence of major pharmaceutical and biopharmaceutical companies, increased R&D activities, a growing number of product launches, a high prevalence of chronic diseases, and supportive government regulations for research and development facilities. Additionally, stringent healthcare regulations, strict drug approval requirements, rising public awareness of drug safety, and the adoption of advanced technologies, including gene and cell therapies for treating hematologic malignancies, are further driving the expansion of the regional market.

Infectious Diseases Drive Growth in Transport Media Industry: Market to Expand at 4.6% CAGR

In 2024, the worldwide transport media industry size stood at USD 3,218.9 million, and it is projected to advance at a CAGR of 4.6% over the projection period, to touch USD 4,210.6 million by the end of 2030. This is because of the increasing occurrence of communicable illnesses, like influenza and herpes; rising demand for pre-clinical and diagnostic testing, rising research and development on viral diseases, and the growing count of steps taken by governments to drive the acceptance of testing kits.

Just like the high number of deaths from influenza (around 400,000 in 2022) and the millions suffering from herpes (around 4 billion), the rise of infectious diseases means more people need diagnosis and treatment. This, in turn, fuels the market for tools used in this process.

To keep samples safe during travel from collection to testing, scientists developed special transport media. These can be adjusted depending on the suspected germ. The COVID-19 pandemic, with its massive increase in testing, is a prime example of how this market boomed.

After all, accurate tests rely on high-quality samples, and that means proper storage and transport before reaching the lab. Viral transport media became a go-to solution, leading life science and biotech companies to ramp up production of these tools for transporting swabs from patients to diagnostic labs.

Key Insights

In 2023, the viral transport media category had a share of, 35%.

This growth can be credited to the sudden outbreak of communicable diseases, like COVID-19 and monkeypox, which generates the need for analysis and testing among diseased individuals.

World Health Organization issued and executed biosafety lab rules in 2022 for collecting, testing, and handling samples containing the monkeypox virus, including proper transportation using viral transport solutions.

The rising number of pharmaceutical and biotechnology companies, along with academic research institutes, increases the demand for viral transport solutions.

Governments are increasing flu awareness through campaigns, emphasizing prevention and early diagnosis, which boosts test numbers.

Diagnostic laboratories held the largest share due to increased COVID-19 testing demand and setup.

Virus genome mutations necessitate identifying specific strains, adding pressure on diagnostic labs.

Increased awareness of diagnostic testing and government support drive market growth.

WHO projects the elderly population to rise from 1 billion in 2020 to 1.7 billion in 2030, increasing healthcare service demand.

Infectious diseases are more common in the elderly, escalating diagnostic test volumes.

North America dominates the market due to high diagnostic test counts, numerous pharma and biotech companies, and a robust healthcare system.

Rising infectious disease prevalence drives revenue for market players.

Regional government initiatives for advanced testing solutions contribute to North American market growth.

In 2020, about 3.5 million people visited U.S. emergency rooms for infectious diseases.

Numerous market players in the U.S. ensure easy product availability.

In April 2021, COPAN Diagnostics launched the UniVerse automated molecular specimen preparation instrument in North America.

The APAC region is expected to grow the fastest due to high infectious disease incidence, especially in China and India.

A large population with infectious diseases in APAC leads to a high demand for diagnostics.

Many market players are addressing the unmet diagnostic needs in APAC.

Augmented Analytics: A Game-Changer in Business Intelligence

Augmented Analytics: Enhancing Human-Data Interaction Through AI and ML

Augmented analytics, powered by artificial intelligence (AI) and machine learning (ML), significantly enhances human interaction with data by making it more accessible and insightful. This approach involves the use of specialized tools and software that provide analytical capabilities, such as generating insights, offering guidance on queries, and referencing relevant data, enabling a broader range of users to benefit from advanced analytics.

Augmented analytics leverages AI and ML to support various aspects of data analysis, from data preparation to insight generation and explanation. This technology augments traditional analytics and business intelligence platforms, making it easier for users to explore and interpret data.

By empowering both expert and non-expert data scientists, augmented analytics enhances the management, deployment, and development of machine learning models and data science projects. The market for augmented analytics is rapidly expanding, with projections estimating a compound annual growth rate (CAGR) of 27.4% from 2021 to 2030, potentially reaching USD 78,229.7 million by 2030.

The Role of Machine Learning in Augmented Analytics

Machine learning, a key component of augmented analytics, automates the extraction of algorithms and models from data, facilitating faster and more accurate analysis. ML reduces or eliminates tedious tasks, enabling users to gain insights and make data-driven decisions more quickly. This includes processes like data shaping, cleaning, and filtering, which are crucial for in-depth analysis.

Advantages of Augmented Analytics

Enhanced Data Management

For most businesses, refining data is a continuous process. However, achieving better data analytics cannot be delayed until data is flawless. Modern augmented analytics platforms aid businesses in maintaining data governance and quality, allowing them to process information faster and solve business challenges more efficiently. A centralized data view enables companies to deliver superior customer experiences and increase profitability.

Efficient Data Analysis Experience

The current landscape of data analytics is often fragmented by distributed workflows and point solutions. Augmented analytics platforms provide a streamlined user experience that addresses key business needs. For example, integrating enhanced insights into a simple, built-in search interface can make end-user workflows more intuitive. This leads to greater adoption and utilization by business users.

Applications of Augmented Analytics in Healthcare

Patient care quality is heavily influenced by factors such as wait times. Augmented analytics enables hospital staff to engage with and understand performance data, improving areas like operational costs, staffing, patient turnover, and overall patient experience. The quality of medical care and patient outcomes is partly dependent on the capabilities of healthcare professionals. Augmented analytics fills a critical gap by offering higher-quality training to a broader audience at a lower cost.

The growth of the augmented analytics industry is driven by increasing awareness of business analytics tools and the rising volume of complex business data worldwide.

Vaccine Adjuvants Industry Expands with Increased Adoption in Combating Infectious Diseases

In 2024, the worldwide vaccine adjuvants industry was valued at USD 930.7 million, which is projected to attain USD 1,375.9 million by the end of 2030, advancing at a CAGR of 6.7% over the projection period.

This development of the market can be credited to the increasing occurrence of communicable illnesses and the mounting usage of vaccine adjuvants, as a result. There has been a tremendous surge in the load of infectious diseases, like TB, HIV, and malaria, in recent years. This has led to a surge in the utilization of therapeutic and prophylactic vaccines, which, ultimately, has fuelled the demand for adjuvants.

Government officials and pharmaceutical and biotechnology firms have recognized the importance of infectious disease research following the emergence of the novel coronavirus. For example, the U.S. Department of Health and Human Services, through the Health Resources and Services Administration (HRSA), introduced a new initiative in November 2022.

This USD 350 million initiative aims to boost COVID-19 vaccination rates in communities served by HRSA-supported health centers, focusing particularly on marginalized populations. Additionally, the U.S. has committed USD 122 million to three prominent medical research institutions in India to enhance early detection of disease threats and ensure swift and effective responses to prevent future epidemics.

Key Insights

• Particulate Category: Particulates held the largest market share of 35% in 2023, driven by products like alum, virosomes, and cytokines known for enhancing vaccine efficacy.

• Emulsions also showed significant growth due to increased adoption in adjuvanted vaccines against SARS-CoV-2.

• Pathogen Category Growth: The pathogen category is expected to grow the fastest at a CAGR of 7.5%, supported by advancements like Monophosphoryl lipid A used in vaccines such as Cervarix.

• Infectious diseases led the disease type segment with a 45% share in 2023, driven by rising incidences of hepatitis, influenza, and malaria.

• The cancer category is set to expand rapidly due to active research on targeted therapies, including the use of adjuvanted vaccines like Cervarix.

• Intramuscular administration captured the largest market share (30%) in 2023, favored for its immunological specificity and effectiveness in delivering vaccines such as HPV and influenza.

• Intradermal and Intranasal Categories: Intradermal administration is projected to grow significantly due to prolonged action and absorption benefits, while intranasal vaccines are gaining popularity for their comfort and efficacy post-COVID-19.

• North America dominated the market with a 45% share in 2023, driven by top players, advanced healthcare infrastructure, technological innovations, and supportive healthcare policies.

• Europe is expected to hold a substantial share, driven by an aging population, increasing chronic diseases, and robust introduction of new products like the VLA2001 COVID-19 vaccine.